Internal Server Error

Cosette Pharmaceuticals - About the company

Cosette Pharmaceuticals is a funded company based in South Plainfield (United States), founded in 2018. It operates as a Manufacturer of diversified generic drugs.

Company Details

Email ID
*****@cosettepharma.com
Phone Number
+1 **********
Registered Address
South Plainfield, New Jersey
Key Metrics
Founded Year
2018
Location
South Plainfield, United States
Stage
Funding Raised
Employee Count
248 as on Sep 30, 2026
Investment & Acquisitions
Sign up to download Cosette Pharmaceuticals' company profile

Cosette Pharmaceuticals's funding and investors

Cosette Pharmaceuticals is a funded company. Cosette Pharmaceuticals has 2 institutional investors.

Cosette Pharmaceuticals' founders and board of directors

Founder? Claim Profile

Cosette Pharmaceuticals' employee count trend

Cosette Pharmaceuticals has 248 employees as of Sep 26. Here is Cosette Pharmaceuticals's employee count trend over the years:
Employee count trend for Cosette Pharmaceuticals
lockUncover Cosette Pharmaceuticals' growth story! Sign up today!
chrome_extension_cta_illustration
Access Tracxn on any website
Our Google Chrome extension lets you view company details while browsing their websites
Install Tracxn Extension

Cosette Pharmaceuticals's Investments and acquisitions

Cosette Pharmaceuticals has not made any investments yet. Cosette Pharmaceuticals has made 6 acquisitions.
Here is the list of latest three $acquisitions:
Date of Investment/Acquisition
Type
Company Name
Founded Year
Location
Feb 20, 2025
Acquisition
1845
Adelaide (Australia)
Jul 10, 2024
Acquisition
2000
Jan 03, 2024
Acquisition
2017
Cranbury (United States)
lockWant to know more about where corporates are investing? Sign up today!
See all acquisitions by Cosette Pharmaceuticals

Reports related to Cosette Pharmaceuticals

Here is the latest report on Cosette Pharmaceuticals's geography:

News related to Cosette Pharmaceuticals

lockFilter this list
Media has covered Cosette Pharmaceuticals for a total of 12 events in the last 1 year, 3 of them have been about people movement and 2 about company updates.
•
FDA approves Cosette’s Evoxac oral solution for Sjögren’s diseasePharmaceutical Technology•Oct 21, 2026•Cosette Pharmaceuticals
•
Cosette Pharmaceuticals Appoints David Bell as Chief Commercial Officer (Brands)Business Wire•May 19, 2026•Cosette Pharmaceuticals
•
Termination of Proposed Acquisition of Mayne PharmaFinancial Times•Dec 12, 2025•Cosette Pharmaceuticals, Mayne Pharma
•
Treasurer blocks US takeover of Aussie pharma companyThe West Australian•Nov 21, 2025•Mayne Pharma, Cosette Pharmaceuticals
•
Cosette Pharmaceuticals Appoints Jeff Neubig as VP of Quality & Regulatory AffairsWorld Business Outlook•Jun 30, 2025•Cosette Pharmaceuticals, LTS Lohmann
•
Mayne Pharma Halts Trading Amid Acquisition TalksTipRanks•May 19, 2025•Mayne Pharma, Cosette Pharmaceuticals
lockGet curated news about company updates, funding rounds, M&A deals and others. Sign up today!

FAQs about Cosette Pharmaceuticals

Explore our recently published companies
Tracxn powers 1,000+ customers across 30+ countries
Accel PartnersPartechIN-Q-TEL - USFujitsuTenityStanford